MedPath

Triplixam 10 mg/ 2.5 mg/ 10 mg, film-coated tablets

Registration Number: MAL15125060AZ

Approved
Approval ID

c7f944b4786bdbf0

Registration Number

MAL15125060AZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types2 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (2)

30tablet TabletsAvailable
Package Size: 30tablet Tablets
Status: NPRA Approved
10 TabletsAvailable
Package Size: 10 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (3)

PERINDOPRIL ARGININEActive
Monograph: 培哚普利
AMLODIPINE BESILATEActive
Monograph: 氨氯地平
INDAPAMIDEActive
Monograph: 吲达帕胺

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Triplixam 10 mg/ 2.5 mg/ 10 mg, film-coated tablets - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform